Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries

Simple item page
dc.contributor.authorRoberto José Pessoa de Magalhães Filho
dc.contributor.authorEdvan de Queiroz Crusoé
dc.contributor.authorEloísa Riva
dc.contributor.authorWillen Bujan
dc.contributor.authorGuilhermo Conte
dc.contributor.authorJuan Ramon Navarro Cabrera
dc.contributor.authorDiana Katerine Garcia
dc.contributor.authorGuilhermo Quintero Vega
dc.contributor.authorJosé Antonio Rosendo Macías
dc.contributor.authorJose Willian Oliveros Alvear
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:09:21Z
dc.date.available2026-03-22T14:09:21Z
dc.date.issued2018
dc.descriptionCitaciones: 41
dc.identifier.doi10.1016/j.clml.2018.08.005
dc.identifier.urihttps://doi.org/10.1016/j.clml.2018.08.005
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/44863
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofClinical Lymphoma Myeloma & Leukemia
dc.sourceUniversidade Federal do Rio de Janeiro
dc.subjectMultiple myeloma
dc.subjectBortezomib
dc.subjectLenalidomide
dc.subjectThalidomide
dc.subjectMedicine
dc.subjectMelphalan
dc.subjectTransplantation
dc.subjectFamily medicine
dc.subjectOncology
dc.subjectInternal medicine
dc.titleAnalysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries
dc.typearticle

Files

Collections

Artículo Científico Publicado